Lifevantage (NASDAQ: LFVN) reported Q2 EPS of $0.02, $0.01 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $56 million versus the consensus estimate of $54.95 million.

Lifevantage sees FY2014 EPS of $0.14-$0.16, versus the consensus of $0.11. Lifevantage sees FY2014 revenue of $225-235 million, versus the consensus of $212.9 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.